Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on: January 04,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on:January 04,2024

Trial results support 'new gold standard' for head and neck cancer radiotherapy

byInstitute of Cancer ResearchRadiotherapy IMRT. Credit: Jan Chlebik/the ICRPhase III trial results on a precision radiotherapy technique support a "new gold standard" for treating hea

Updated on: January 04,2024

Trial results support 'new gold standard' for head and neck cancer radiotherapy

byInstitute of Cancer ResearchRadiotherapy IMRT. Credit: Jan Chlebik/the ICRPhase III trial results on a precision radiotherapy technique support a "new gold standard" for treating hea

Updated on:January 04,2024

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorou

Updated on: May 16,2024

Researchers demonstrate that a machine learning model predicts oxaliplatin benefit

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe current standard of care for treating patients with stage 3 colon cancer is to use adjuvant therapy with FOLFOX, a combination of the drugs fluorou

Updated on:May 16,2024

Blood cancer research points to new treatment for bone marrow cancer

byUniversity of VirginiaDeletion of IL-1R1 preferentially inhibits Jak2V617F mutant hematopoietic stem/progenitor cells.aA scheme on competitive BM transplantation approach to assess

Updated on: January 15,2024

Blood cancer research points to new treatment for bone marrow cancer

byUniversity of VirginiaDeletion of IL-1R1 preferentially inhibits Jak2V617F mutant hematopoietic stem/progenitor cells.aA scheme on competitive BM transplantation approach to assess

Updated on:January 15,2024

Report suggests a big improvement in lung cancer survival

by Carole Tanzer MillerMore people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows."There is more work to do, but I am incredi

Updated on: December 01,2024

Report suggests a big improvement in lung cancer survival

by Carole Tanzer MillerMore people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows."There is more work to do, but I am incredi

Updated on:December 01,2024

Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?

by Impact Journals LLCRole for ABCB1 in PDAC chemoresistance. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28597A new editorial paper titled "Targeting ABC transporters in PDAC—p

Updated on: July 11,2024

Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?

by Impact Journals LLCRole for ABCB1 in PDAC chemoresistance. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28597A new editorial paper titled "Targeting ABC transporters in PDAC—p

Updated on:July 11,2024

Researchers identify barriers to breast cancer screening in vulnerable populations

by Sbarro Health Research OrganizationCredit: Unsplash/CC0 Public DomainWomen of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.In order to

Updated on: February 18,2024

Researchers identify barriers to breast cancer screening in vulnerable populations

by Sbarro Health Research OrganizationCredit: Unsplash/CC0 Public DomainWomen of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.In order to

Updated on:February 18,2024

Researchers ID risks for second childhood cancers

by Jeremy OlsonCredit: CC0 Public DomainChemotherapy and radiation treatments have helped children survive cancer. Now University of Minnesota researchers are trying to find the ideal combinations tha

Updated on: June 22,2024

Researchers ID risks for second childhood cancers

by Jeremy OlsonCredit: CC0 Public DomainChemotherapy and radiation treatments have helped children survive cancer. Now University of Minnesota researchers are trying to find the ideal combinations tha

Updated on:June 22,2024

Cancerous brain tumor cells may be at 'critical point' between order and disorder, study suggests

by Noah Fromson,University of MichiganCredit: Justine Ross and Jacob Dwyer / Michigan MedicineGlioblastoma is the most aggressive form of brain cancer. Despite decades of major efforts and clini

Updated on: January 22,2024

Cancerous brain tumor cells may be at 'critical point' between order and disorder, study suggests

by Noah Fromson,University of MichiganCredit: Justine Ross and Jacob Dwyer / Michigan MedicineGlioblastoma is the most aggressive form of brain cancer. Despite decades of major efforts and clini

Updated on:January 22,2024

How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo

Updated on: May 09,2024

How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo

Updated on:May 09,2024

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023

Study offers new insights into earliest stages of brain tumor development

by University of PlymouthCredit:EMBO Reports(2024). DOI: 10.1038/s44319-023-00017-1Scientists working to better understand and find a cure for brain tumors have made progress in ident

Updated on: March 20,2024

Study offers new insights into earliest stages of brain tumor development

by University of PlymouthCredit:EMBO Reports(2024). DOI: 10.1038/s44319-023-00017-1Scientists working to better understand and find a cure for brain tumors have made progress in ident

Updated on:March 20,2024